West Pharmaceutical Services, Inc. Financial Ratios — WST

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	11.67	11.45	14.4	14.59	10.05	13.86	13.18	16.11	16.44	20.16	30.49	21.38	18.12	13.11	11.8
Return on Assets (%)	5.61	5.45	6.94	7.61	5.68	8.42	8.42	10.77	11.19	13.48	21.67	16.91	15.94	13.19	12.48
Return on Capital (%)	8.9	8.51	10.63	11.34	8.4	11.49	11.48	14.44	14.34	17.26	26.8	19.34	16.75	12.18	10.99
Return on Invested Capital (%)	8.8	8.72	9.57	10.01	10.41	11.95	10.23	12.99	13.54	16.6	26.48	22.02	18.62	15.43	15.43
Gross Margin (%)	28.46	30.61	31.77	31.5	32.56	33.23	32.07	31.76	32.92	35.76	41.52	39.36	38.28	34.51	35.91
EBITDA Margin (%)	16.34	16.84	18.06	19.04	19.12	20.92	20.29	20.18	21.86	24.59	31.17	30.53	28.64	25.79	26.27
Operating Margin (%)	9.99	10.77	11.83	12.71	12.7	14.91	14.25	14.1	16.24	19.51	26.85	26.35	23.98	20.42	20.69
Incremental Operating Margin (%)	14.38	23.35	25	35.28	12.96	43.18	3.11	12.17	46.2	39.12	49.85	1.08	-84.9	205.83	24.99
Pretax Margin (%)	7.77	8.58	10.75	11.89	8.29	12.58	13.91	14.02	15.86	18.69	26.45	23.55	23.66	20.24	19.55
Profit Margin (%)	6.33	6.37	8.21	8.94	6.83	9.52	9.42	12.05	13.14	16.13	23.37	20.3	20.12	17.03	16.06
Net Income to Common Margin (%)	6.33	6.37	8.21	8.94	6.83	9.52	9.42	12.05	13.14	16.13	23.37	20.3	20.12	17.03	16.06
Effective Tax Rate (%)	25.35	30.11	27.33	27.93	22.65	28.66	36.38	17.2	20.22	18.07	14.31	16.87	17.52	18.36	20.24
Dvd Payout Ratio (%)	30.73	30.86	23.78	22.9	33.89	24.93	25.95	20.35	18.66	13.89	7.72	9.23	9.61	12	12.4
Sustainable Growth Rate (%)	8.08	7.91	10.98	11.25	6.64	10.4	9.76	12.83	13.37	17.36	28.14	19.4	16.38	11.54	10.34

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	349	412	374	336	298	229	197	196	329	326	325	318	309	302	321
ST Debt	50	33	2	27	69	2	- -	- -	12	12	54	18	152	18	23
LT Debt	299	379	371	308	229	226	197	196	317	313	272	300	157	284	298
Total Debt/EBITDA	1.79	1.93	1.51	1.24	1.11	0.72	0.61	0.57	0.82	0.62	0.37	0.36	0.37	0.41	0.4
Net Debt/EBITDA	1.32	1.17	0.58	0.3	0.09	0.08	-0.12	-0.41	-0.45	-0.68	-0.58	-0.78	-0.77	-0.38	-0.73
Total Debt/EBIT	2.93	3.02	2.31	1.86	1.68	1.02	0.86	0.81	1.1	0.78	0.43	0.42	0.44	0.51	0.5
Net Debt/EBIT	2.16	1.83	0.89	0.44	0.13	0.11	-0.17	-0.58	-0.61	-0.86	-0.67	-0.9	-0.91	-0.48	-0.93
EBITDA to Interest Expense	10.7	12.77	14.54	16.4	18.99	38.98	41.6	41.26	47.32	64.39	107.62	111.57	93.86	248.77	1,615
EBITDA-CapEx/Interest Expense	10.63	12.73	14.31	16.39	18.99	38.98	41.6	41.26	47.32	64.39	107.62	111.57	93.86	248.77	1,615
EBIT to Interest Expense	6.54	8.17	9.52	10.95	12.61	27.78	29.21	28.83	35.15	51.09	92.71	96.3	78.6	196.97	1,272.2
Interest Expense	18	17	17	16	14	8	8	8	8	8	8	8	9	3	- -
Common Equity/Total Assets	48.11	47.13	49.21	55.1	57.97	63.49	64.26	69.34	66.98	66.77	74.7	83.13	92.5	109.11	102.9
Long-Term Debt/Equity (%)	45.7	51.97	40.96	32.22	22.36	20.24	15.39	14.04	20.18	16.89	11.64	11.16	5.46	10.6	9.4
Long-Term Debt/Capital (%)	29.27	32.98	31.04	24.56	17.87	17.15	14.13	12.5	16.73	14.3	9.7	9.01	4.08	6.65	6.33
Long-Term Debt/Total Assets (%)	21.39	24.22	22.21	18.46	13.5	13.18	10.58	9.9	13.56	11.21	8.2	8.29	4.11	7.81	6.99
Total Debt/Equity (%)	53.35	56.45	41.21	35.06	29.12	20.46	15.39	14.04	20.93	17.56	13.93	11.84	10.73	11.27	10.11
Total Debt/Capital (%)	34.17	35.83	31.23	26.72	23.28	17.34	14.13	12.5	17.35	14.86	11.61	9.56	8.02	7.07	6.81
Total Debt/Total Assets (%)	24.97	26.31	22.34	20.09	17.59	13.32	10.58	9.91	14.06	11.66	9.82	8.79	8.07	8.3	7.52
Net Debt to Equity	39.33	34.24	15.83	8.38	2.3	2.29	-3.04	-10.12	-11.56	-19.43	-21.82	-25.53	-22.46	-10.51	-18.53
Net Debt/Capital (%)	27.68	25.3	14.85	8.02	2.35	2.29	-3.36	-11.48	-12.47	-22.87	-25	-28.2	-21.59	-7.43	-15
EBITDA	195	213	247	271	268	316	324	347	402	528	882	881	845	746	808
EBITDA-CapEx	193	213	243	270	268	316	324	347	402	528	882	881	845	746	808
Operating Income (Loss)	119	136	162	181	178	225	228	242	299	419	760	761	707	591	636

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.49	0.67	1	1.01	0.87	0.84	0.84	1.19	1.29	1.22	1.28	1.72	1.27	0.88	1.21
Current Ratio	1.94	2.13	2.75	2.61	2.14	2.66	2.66	3.15	3.1	2.73	2.93	3.7	2.88	2.79	3.02
Quick Ratio	1.09	1.33	1.79	1.72	1.45	1.67	1.75	2.21	2.22	1.99	2.11	2.7	2.03	1.88	2.09
CFO/Avg Current Liab	0.63	0.74	0.88	0.75	0.75	0.79	1.01	1.02	1.17	1.12	1.06	1.3	1.3	1.07	1.25
Common Equity/Total Assets	48.11	47.13	49.21	55.1	57.97	63.49	64.26	69.34	66.98	66.77	74.7	83.13	92.5	109.11	102.9
Long-Term Debt/Equity (%)	45.7	51.97	40.96	32.22	22.36	20.24	15.39	14.04	20.18	16.89	11.64	11.16	5.46	10.6	9.4
Long-Term Debt/Capital (%)	29.27	32.98	31.04	24.56	17.87	17.15	14.13	12.5	16.73	14.3	9.7	9.01	4.08	6.65	6.33
Long-Term Debt/Total Assets (%)	21.39	24.22	22.21	18.46	13.5	13.18	10.58	9.9	13.56	11.21	8.2	8.29	4.11	7.81	6.99
Total Debt/Equity (%)	53.35	56.45	41.21	35.06	29.12	20.46	15.39	14.04	20.93	17.56	13.93	11.84	10.73	11.27	10.11
Total Debt/Capital (%)	34.17	35.83	31.23	26.72	23.28	17.34	14.13	12.5	17.35	14.86	11.61	9.56	8.02	7.07	6.81
Total Debt/Total Assets (%)	24.97	26.31	22.34	20.09	17.59	13.32	10.58	9.91	14.06	11.66	9.82	8.79	8.07	8.3	7.52
CFO/Total Liabilities	17.56	22.44	28.82	25.66	31.64	36.62	45.17	49.54	47.8	50.3	59.69	77.69	81.87	67.98	68.99
CFO/CapEx	93.36	267.71	56.54	914.5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	3.29	3.54	5.01	5.66	6.3	8.89	10.13	10.24	11.35	16.07	24.59	14.5	19.72	18.21	14.01

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	8.72	7.86	7.59	7.79	7.77	7.9	7.05	6.34	6.06	6.09	6.48	5.79	5.79	5.44	5.46
Days Sales Outstanding	41.88	46.43	48.11	46.83	46.99	46.18	51.78	57.53	60.26	59.9	56.35	62.99	63.07	67.15	66.9
Inventory Turnover	5.71	5.6	5.51	5.43	5.21	5.3	5.24	5.45	5.48	4.95	4.73	4.41	4.29	4.67	4.8
Days Inventory Outstanding	63.93	65.22	66.28	67.18	70.1	68.89	69.64	66.91	66.57	73.71	77.12	82.69	85.16	78.18	76.04
Accounts Payable Turnover	11.21	9.23	8.99	9.27	8.47	8.49	8.47	8.72	8.74	7.92	7.69	7.99	8.04	7.63	8.26
Accounts Payable Turnover Days	32.55	39.55	40.58	39.38	43.11	43.01	43.07	41.83	41.75	46.09	47.44	45.71	45.39	47.86	44.17
Cash Conversion Cycle	73.26	72.09	73.8	74.62	73.98	72.06	78.35	82.61	85.08	87.52	86.03	99.97	102.83	97.48	98.78
Inventory to Cash Days	-22.05	-18.78	-18.17	-20.36	-23.11	-22.71	-17.86	-9.38	-6.31	-13.81	-20.77	-19.7	-22.09	-11.04	-9.14
Inventories	152	162	177	182	181	199	215	214	236	321	378	415	435	377	444
Raw Materials	65	68	72	80	74	78	89	82	101	134	154	171	172	167	163
Work In Process	20	24	25	26	30	29	32	42	37	55	64	79	87	65	103
Finished Goods	67	71	80	76	77	92	95	90	97	133	161	165	175	145	178
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	1,279	1,862	3,415	3,775	4,336	6,218	7,292	7,244	11,124	20,937	34,894	17,510	26,163	23,912	19,893
- Cash & Cash Equivalents	92	162	230	255	275	203	236	337	439	616	763	894	854	485	791
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	349	412	374	336	298	229	197	196	329	326	325	318	309	302	321
Enterprise Value	1,510	2,099	3,551	3,855	4,359	6,244	7,253	7,103	11,015	20,647	34,457	16,934	25,618	23,730	19,422
Total Capital	1,022	1,149	1,196	1,256	1,281	1,319	1,394	1,568	1,898	2,191	2,801	3,324	3,851	4,278	4,715
Total Debt/Capital (%)	34.17	35.83	31.23	26.72	23.28	17.34	14.13	12.5	17.35	14.86	11.61	9.56	8.02	7.07	6.81
Total Debt / EV	0.23	0.2	0.11	0.09	0.07	0.04	0.03	0.03	0.03	0.02	0.01	0.02	0.01	0.01	0.02
EV/Sales	1.27	1.66	2.59	2.71	3.11	4.14	4.54	4.14	5.99	9.62	12.17	5.87	8.68	8.2	6.32
EV/EBITDA	7.75	9.84	14.37	14.25	16.28	19.78	22.35	20.49	27.39	39.1	39.04	19.21	30.33	31.8	24.05
EV/EBIT	12.68	15.39	21.93	21.35	24.52	27.75	31.84	29.33	36.86	49.29	45.33	22.26	36.21	40.16	30.53
EV/Cash Flow to Firm	10.47	10.54	15.25	19.79	19.52	27.73	27.04	24.03	29.45	43.08	58.3	23.18	32.68	36.18	25.72
EV/Free Cash Flow to Firm	10.37	10.51	15	19.77	19.52	27.73	27.04	24.03	29.45	43.08	58.3	23.18	32.68	36.18	25.72
Diluted Market Cap	1,405	1,966	3,503	3,876	4,444	6,362	7,479	7,391	11,335	21,475	35,785	17,840	26,515	24,141	20,003
Diluted Enterprise Value	1,662	2,215	3,646	3,956	4,468	6,388	7,440	7,250	11,225	21,185	35,348	17,263	25,970	23,959	19,532
EV per Share	22.41	30.87	51.01	54.37	60.55	85.18	98.14	96.12	148.85	279.39	463.13	227.6	344.79	325.06	268.64
TTM Sales	1,192	1,266	1,368	1,421	1,400	1,509	1,599	1,717	1,840	2,147	2,832	2,887	2,950	2,893	3,074
TTM EBITDA	195	213	247	271	268	316	324	347	402	528	882	881	845	746	808
TTM Operating Income	119	136	162	181	178	225	228	242	299	419	760	761	707	591	636
TTM Cash Flow to Firm	144	199	233	195	223	225	268	296	374	479	591	731	784	656	755
TTM Free Cash Flow to Firm	146	200	237	195	223	225	268	296	374	479	591	731	784	656	755

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	10.63	10.45	15.61	21.17	20.92	29	28.41	25.61	30.87	45.45	61.28	24.64	34.15	36.95	26.5
EV/EBIT	12.68	15.39	21.93	21.35	24.52	27.75	31.84	29.33	36.86	49.29	45.33	22.26	36.21	40.16	30.53
Enterprise Value	1,510	2,099	3,551	3,855	4,359	6,244	7,253	7,103	11,015	20,647	34,457	16,934	25,618	23,730	19,422
Low Price	17.75	18.68	27.31	39.11	48.66	53.88	77.97	82.74	93.08	124.53	253.86	206.19	225.66	265	187.43
EV/Sales	1.27	1.66	2.59	2.71	3.11	4.14	4.54	4.14	5.99	9.62	12.17	5.87	8.68	8.2	6.32
EV/EBITDA	7.75	9.84	14.37	14.25	16.28	19.78	22.35	20.49	27.39	39.1	39.04	19.21	30.33	31.8	24.05
Price/Earnings	16.94	23.07	30.41	29.7	45.35	43.3	48.39	35.01	46.03	60.48	52.73	29.89	44.09	48.53	40.29
Price/Earnings Average	18.46	19.98	22.95	25.43	42.88	37.19	44.65	36.28	38.77	47.94	41.4	39.9	43.54	49.72	36.82
Price/Earnings High	21.41	23.6	31.36	30.84	48.65	44.15	50.69	44.68	46.57	65.11	53.44	59.43	52.05	61.3	51.09
Price/Earnings Low	15.85	15.74	16.93	21.82	36.65	27.5	38.23	29.55	28.5	26.58	28.54	26.18	28.26	39.26	27.45
Price/Book Value	1.9	2.53	4.15	4.1	4.41	5.7	6.09	5.28	7.09	11.22	14.1	5.82	7.39	6.01	4.53
Price/Book Value Average	2.07	2.19	3.13	3.51	4.17	4.9	5.62	5.47	5.98	8.9	11.07	7.78	7.29	6.16	4.14
Price/Book Value High	2.4	2.58	4.28	4.26	4.73	5.82	6.38	6.74	7.18	12.08	14.29	11.58	8.72	7.6	5.74
Price/Book Value Low	1.78	1.72	2.31	3.01	3.57	3.62	4.81	4.46	4.39	4.93	7.63	5.1	4.73	4.87	3.08
Price/Tangible Book Value	2.6	3.29	4.59	4.68	4.92	6.27	6.34	5.7	7.75	12.22	15.84	6.84	9.49	9.32	6.5
Price/Tangible Book Value Average	2.84	2.85	3.46	4.01	4.65	5.39	5.85	5.91	6.53	9.69	12.44	9.14	9.37	9.55	5.94
Price/Tangible Book Value High	3.29	3.37	4.73	4.86	5.27	6.4	6.64	7.28	7.84	13.16	16.06	13.61	11.2	11.77	8.25
Price/Tangible Book Value Low	2.43	2.25	2.56	3.44	3.97	3.98	5.01	4.81	4.8	5.37	8.58	5.99	6.08	7.54	4.43
Price/Sales	1.07	1.47	2.5	2.66	3.1	4.12	4.56	4.22	6.05	9.75	12.32	6.07	8.87	8.26	6.47
Price/Sales Average	1.17	1.27	1.88	2.27	2.93	3.54	4.21	4.37	5.09	7.73	9.68	8.1	8.76	8.47	5.91
Price/Sales High	1.36	1.5	2.57	2.76	3.32	4.2	4.78	5.38	6.12	10.5	12.49	12.06	10.47	10.44	8.21
Price/Sales Low	1	1	1.39	1.95	2.5	2.62	3.6	3.56	3.74	4.29	6.67	5.31	5.68	6.69	4.41
Price/Cash Flow	9.79	9.94	15.49	20.64	20.41	28.34	27.69	25.1	30.3	44.31	59.75	24.19	33.69	36.6	26.35
Price/Cash Flow Average	10.66	8.6	11.69	17.67	19.3	24.34	25.56	26.01	25.52	35.12	46.92	32.29	33.27	37.49	24.08
Price/Cash Flow High	12.37	10.16	15.97	21.43	21.89	28.9	29.01	32.03	30.66	47.7	60.56	48.1	39.78	46.22	33.42
Price/Cash Flow Low	9.15	6.78	8.62	15.16	16.49	18	21.88	21.19	18.76	19.48	32.34	21.19	21.59	29.61	17.95
Price/Free Cash Flow Average	11.58	9.05	11.78	18.13	19.78	24.91	26.22	26.54	26	36.03	48.11	32.9	33.72	37.85	24.21
Price/Free Cash Flow High	13.43	10.69	16.1	21.98	22.44	29.57	29.76	32.68	31.24	48.93	62.1	49	40.31	46.66	33.6
Price/Free Cash Flow Low	9.94	7.13	8.69	15.55	16.91	18.42	22.45	21.62	19.11	19.98	33.17	21.59	21.88	29.89	18.05
EV/Sales Average	1.38	1.47	1.99	2.33	2.95	3.56	4.18	4.29	5.03	7.6	9.52	7.9	8.57	8.4	5.76
EV/Sales High	1.57	1.7	2.68	2.81	3.34	4.22	4.75	5.3	6.06	10.36	12.34	11.86	10.29	10.38	8.05
EV/Sales Low	1.22	1.2	1.49	2.01	2.52	2.63	3.58	3.48	3.68	4.15	6.52	5.11	5.5	6.62	4.26
EV/EBITDA Average	8.48	8.73	11.01	12.24	15.4	17	20.62	21.25	23.03	30.88	30.55	25.87	29.94	32.58	21.93
EV/EBITDA High	9.62	10.1	14.83	14.78	17.46	20.16	23.42	26.26	27.72	42.14	39.58	38.85	35.92	40.22	30.66
EV/EBITDA Low	7.46	7.13	8.27	10.54	13.18	12.59	17.64	17.23	16.85	16.88	20.91	16.75	19.2	25.68	16.2
EV/EBIT Average	13.86	13.65	16.8	18.34	23.19	23.85	29.37	30.41	30.99	38.93	35.47	29.97	35.75	41.15	27.84
EV/EBIT High	15.73	15.79	22.64	22.15	26.29	28.29	33.36	37.58	37.31	53.11	45.95	45.01	42.89	50.8	38.92
EV/EBIT Low	12.21	11.14	12.63	15.8	19.84	17.67	25.12	24.66	22.68	21.28	24.27	19.41	22.93	32.43	20.56
Last Price	18.98	27.38	49.06	53.24	60.22	84.83	98.67	98.03	150.33	283.31	469.01	235.35	352.12	327.56	275.14
High Price	23.98	28.01	50.6	55.29	64.59	86.5	103.36	125.09	152.12	305	475.35	468.05	415.73	413.7	348.9
Enterprise Value Average	1,651	1,862	2,720	3,313	4,123	5,367	6,691	7,366	9,261	16,306	26,961	22,802	25,289	24,316	17,706
Enterprise Value High	1,874	2,154	3,665	4,000	4,674	6,366	7,599	9,103	11,147	22,250	34,929	34,247	30,344	30,018	24,755
Enterprise Value Low	1,454	1,520	2,044	2,853	3,527	3,975	5,723	5,973	6,778	8,913	18,450	14,764	16,222	19,163	13,081

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	67	69	70	71	72	73	74	74	74	74	74	74	74	72	72
Diluted Weighted Avg Shares	74	72	71	73	74	75	76	75	75	76	76	76	75	74	73
Basic Weighted Avg Shares	67	68	70	71	72	73	74	74	74	74	74	74	74	73	72
Revenue per Share	17.69	18.62	19.66	20.05	19.44	20.59	21.64	23.24	24.86	29.05	38.06	38.8	39.7	39.63	42.52
EBITDA per Share	2.89	3.14	3.55	3.82	3.72	4.31	4.39	4.69	5.44	7.14	11.86	11.85	11.37	10.22	11.17
Operating Income per Share	1.77	2.01	2.33	2.55	2.47	3.07	3.08	3.28	4.04	5.67	10.22	10.23	9.52	8.09	8.8
Basic EPS, GAAP	1.12	1.19	1.61	1.79	1.33	1.96	2.04	2.8	3.27	4.68	8.9	7.88	7.99	6.75	6.83
Basic EPS from Cont Ops	1.12	1.19	1.61	1.79	1.33	1.96	2.04	2.8	3.27	4.68	8.9	7.88	7.99	6.75	6.83
Diluted EPS, GAAP	1.02	1.12	1.57	1.75	1.3	1.91	1.99	2.74	3.21	4.57	8.67	7.73	7.88	6.69	6.79
Diluted EPS from Cont Ops	1.02	1.12	1.57	1.75	1.3	1.91	1.99	2.74	3.21	4.57	8.67	7.73	7.88	6.69	6.79
Dividend per Share	0.34	0.37	0.38	0.41	0.45	0.49	0.53	0.57	0.61	0.65	0.69	0.73	0.77	0.81	0.85
Cash Flow per Share	1.94	2.76	3.17	2.58	2.95	2.99	3.56	3.91	4.96	6.39	7.85	9.73	10.45	8.95	10.44
Free Cash Flow per Basic Share	1.92	2.75	3.11	2.58	2.95	2.99	3.56	3.91	4.96	6.39	7.85	9.73	10.45	8.95	10.44
Cash & Equivalents per Share	1.76	2.56	3.41	3.6	3.81	2.77	3.19	4.57	5.93	8.33	10.25	12.02	11.49	6.64	10.94
Book Value per Share	9.99	10.84	11.82	12.98	13.65	14.87	16.2	18.57	21.19	25.24	33.27	40.41	47.67	54.46	60.77
Tangible Book Value per Share	7.29	8.32	10.69	11.37	12.25	13.52	15.57	17.19	19.4	23.18	29.6	34.4	37.11	35.14	42.3

West Pharmaceutical Services, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)